Preclinical activity of MCLA-128, an ADCC enhanced bispecific IgG1 antibody targeting the HER2:HER3 heterodimer von Geuijen, Cecile, Rovers, Eric, Nijhuis, Roy, den Blanken-Smit, Renate, Visser, Therese, Bartelink, Willem, Kramer, Arjen, Zondag-van der Zande, Vanessa, Clements, Carina, Kaldenberg, Linda, Nieuwenhuizen, Nellie, van Loo, Pieter Fokko, Roovers, Rob, Gallenne, Tristan, Price, Leo, Van Driel Shamsili, Setareh, Bakker, Lex, Logtenberg, Ton, de Kruif, John, Throsby, Mark

Volltext